Event - 01/07/2022 BadenCampus Health Community Meeting Breisach, Registration deadline: 24/06/2022, Meet & Match https://www.gesundheitsindustrie-bw.de/en/event/badencampus-health-community-meeting
Event - 30/09/2022 Start-Up BW Summit 2022 Stuttgart, Registration deadline: 23/05/2022, Messe https://www.gesundheitsindustrie-bw.de/en/event/start-bw-summit-2022
Product testing under real conditions - 11/05/2022 INSPIRE Living Lab: a bridge between industry and the clinic Coming up with innovative ideas and products in the medical care area is highly relevant not only for the further development of Baden-Württemberg as a health region, but also for improving healthcare itself. However, bridging the gap between industry and the clinic often proves difficult. To drive this process forward, the INSPIRE Living Lab was opened at the University Medical Centre Mannheim in 2021.https://www.gesundheitsindustrie-bw.de/en/article/news/inspire-living-lab-bridge-between-industry-and-clinic
Company profile: medicalvalues GmbH - 05/05/2022 medicalvalues – best possible diagnostics thanks to AI The Karlsruhe-based start-up medicalvalues GmbH wants to use its platform to bring together different clinical data sets and thus enable comprehensive medical diagnostics. Artificial intelligence featuring innovative diagnostic algorithms is used to evaluate the data and generate new insights for laboratories and hospitals.https://www.gesundheitsindustrie-bw.de/en/article/news/medicalvalues-best-possible-diagnostics-thanks-ai
Event - 13/10/2022 - 14/10/2022 HealthTech Innovation Days Paris (France), Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/healthtech-innovation-days
Event - 10/05/2022 - 11/05/2022 LSX World Congress London (England), Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/lsx-world-congress
Event - 17/05/2022 International Clinical Trials Day 2022 (ICTD) Berlin and Online, Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/international-clinical-trials-day-2022-ictd
Event - 05/07/2022 - 06/07/2022 FORUM Science & Health – Medicine of Future Fürstenfeldbruck, Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/forum-science-health-medicine-future
Press release - 28/04/2022 Tumors on withdrawal: Amino acid deficiency shrinks childhood tumors Certain childhood tumors have an extreme need for amino acids. Scientists at the Hopp Children's Cancer Center Heidelberg (KiTZ), the German Cancer Research Center (DKFZ), the University of Heidelberg, and HI-STEM* gGmbH have now discovered the molecular mechanisms underlying this and how the cancer cells could be turned off.https://www.gesundheitsindustrie-bw.de/en/article/press-release/tumors-withdrawal-amino-acid-deficiency-shrinks-childhood-tumors
Press release - 26/04/2022 BioLabs Heidelberg announces key partnership and new members in its vibrant life-science community BioLabs, the premier developer and operator of life science coworking spaces, is thrilled to welcome its first three inaugural tenants to its Heidelberg location: Anavo Therapeutics, faCellitate, and Phialogics. BioLabs has announced BioRN, the leading non-profit membership network in the Rhine-Neckar region, as its Founding Partner. This partnership will enable BioLabs to adapt their business model to the German biotech system.https://www.gesundheitsindustrie-bw.de/en/article/press-release/biolabs-heidelberg-announces-key-partnership-and-new-members-its-vibrant-life-science-community
Event - 01/11/2022 - 04/11/2022 Web Summit 2022 Lisboa (Portugal), Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/web-summit-2022
Event - 10/05/2022 Introducing the Global Health EDCTP3 Joint Undertaking Paris (France) and online, Informationsveranstaltung https://www.gesundheitsindustrie-bw.de/en/event/introducing-global-health-edctp3-joint-undertaking
Press release - 25/04/2022 Reprogrammed macrophages promote spread of breast cancer Metastatic breast cancer cells abuse macrophages, a type of immune cell, to promote the settlement of cancer metastases in the lungs. The reprogrammed macrophages stimulate blood vessel cells to secrete a cocktail of metastasis-promoting proteins that are part of the so-called metastatic niche.https://www.gesundheitsindustrie-bw.de/en/article/press-release/reprogrammed-macrophages-promote-spread-breast-cancer
Event - 24/05/2022 Fostering science-industry collaboration: 2nd Bridging the Gap Workshop Online, Online Seminar https://www.gesundheitsindustrie-bw.de/en/event/fostering-science-industry-collaboration-2nd-bridging-gap-workshop
Peptide-based COVID-19 vaccine - 21/04/2022 CoVac-1: T-cell activator against COVID-19 Current vaccines against COVID-19 aim at forming neutralising antibodies that prevent the virus from penetrating the host cells. Since people with impaired B-cell immune responses – which can also occur in cancer or autoimmune diseases – are not able to do this, researchers at the University of Tübingen have developed the peptide-based T-cell activator CoVac-1, which promises broad and long-term immunity.https://www.gesundheitsindustrie-bw.de/en/article/news/covac-1-t-cell-activator-against-covid-19
Event - 26/04/2022 - 28/04/2022 DMEA 2022 Berlin, Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/dmea-2022
Press release - 13/04/2022 Emmy Noether funding for research into drug resistance of blood cancer The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is funding a new Emmy Noether junior research group at the DKFZ for six years with a total of around 2 million euros. The scientists and doctors, who are part of the Clinical Cooperation Unit for Pediatric Leukemia at the KiTZ, are using a new procedure to investigate how cancer cells manipulate the formation of proteins to become resistant to cancer drugs.https://www.gesundheitsindustrie-bw.de/en/article/press-release/emmy-noether-funding-research-drug-resistance-blood-cancer
Event - 16/05/2022 Health Data Futures – Launch Event 2022 Online, Registration deadline: 15/05/2022, Informationsveranstaltung https://www.gesundheitsindustrie-bw.de/en/event/health-data-futures-launch-event-2022
Press release - 12/04/2022 Technology transfer award for PCR rapid test device for infection diagnostics Spindiag GmbH, together with the University of Freiburg and the Hahn-Schickard-Gesellschaft für angewandte Forschung e.V., was awarded the Technology Transfer Prize 2020 from the German Physical Society (DPG) on April 09, 2022 for the development of the PCR-based rapid test system Rhonda.https://www.gesundheitsindustrie-bw.de/en/article/press-release/technology-transfer-award-pcr-rapid-test-device-infection-diagnostics
Funding EIC Accelerator Funding programme, Funded by: European Commission, Submission deadline: 15/06/2022 https://www.gesundheitsindustrie-bw.de/en/database/funding/eic-accelerator
Funding EIC Pathfinder Challenges Funding programme, Funded by: European Commission, Submission deadline: 19/10/2022 https://www.gesundheitsindustrie-bw.de/en/database/funding/eic-pathfinder-challenges
COVIC-19 clinical trial - 07/04/2022 Convalescent plasma for COVID-19 therapy: clinical trial should bring clarity Does it help to treat COVID-19 sufferers with antibodies from people who have recovered from the disease? It seems an obvious idea and has been tested thousands of times. However, there is not yet enough evidence to prove the clinical efficacy of treating COVID-19 patients with convalescent plasma. The transfusion physician Prof. Dr. Hubert Schrezenmeier from Ulm is planning to carry out a follow-up clinical trial to find the missing evidence.https://www.gesundheitsindustrie-bw.de/en/article/news/convalescent-plasma-covid-19-therapy-clinical-trial-should-bring-clarity
Event - 24/05/2022 - 25/05/2022 EIT Health Summit 2022 Stockholm (Sweden), Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/eit-health-summit-2022
Press release - 01/04/2022 FDA approval for targeted radioligand therapy for treatment of metastatic prostate cancer On March 23, 2022, the U.S. Food and Drug Administration (FDA) granted approval to the first targeted radioligand therapy against metastatic prostate cancer based on a joint patent of the German Cancer Research Center (DKFZ) and the University of Heidelberg. The agent significantly improves the chances of survival for those affected.https://www.gesundheitsindustrie-bw.de/en/article/press-release/fda-approval-targeted-radioligand-therapy-treatment-metastatic-prostate-cancer
Press release - 30/03/2022 CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV CureVac N.V. a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced that the first participant was dosed in a Phase 1 study of COVID-19 second-generation mRNA vaccine candidate, CV2CoV, developed in collaboration with GSK.https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevac-and-gsk-start-clinical-development-second-generation-covid-19-vaccine-candidate-cv2cov